| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany
Address correspondence and reprint requests to Joachim Boldt, MD, Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstr. 79, D-67063 Ludwigshafen, Germany. Address e-mail to BoldtJ{at}gmx.net
Definition of the "ideal" intravascular fluid volume replacement strategy still remains a critical problem. This article analyzes studies on volume replacement by using a MEDLINE search of the past 3 years (from January 1, 2000, to December 12, 2002). Forty original studies in humans with a total of 2454 subjects were identified. Five studies were performed in volunteers (n = 113); the other 35 studies (n = 2341) were performed in a variety of patients (e.g., cardiac surgery, trauma patients, children, and intensive care unit patients). The influence of different volume replacement regimens on coagulation was one of the major topics of interest (16 studies with 1183 subjects), and other studies focused on metabolic state, alterations in macro- and microcirculation, volume distribution, and organ function (e.g., kidney function and splanchnic perfusion). Among all synthetic colloids, hydroxyethyl starch (HES) was the solution most often studied. Two new HES preparations have been approved (Hextend®, a balanced hetastarch solution, and a new third-generation HES [130/0.4]). Only two studies used albumin, and no superiority of albumin was found over less expensive synthetic colloids. In almost all studies, the outcome either was no end-point or was not reported. Volume replacement has often been hitherto based on dogma and personal beliefs. Future well performed studies in this area will hopefully help to shed new light on the ideal volume replacement strategy.
IMPLICATIONS: By using a MEDLINE search covering the last 3 yr, the present knowledge on volume replacement regimens was analyzed. Forty studies in humans were identified. New hydroxyethyl starch preparations have shed light on this topic, whereas no additional data supporting the use of albumin have been presented.
This article has been cited by other articles:
![]() |
K. Holte, B. B. Kristensen, L. Valentiner, N. B. Foss, H. Husted, and H. Kehlet Liberal Versus Restrictive Fluid Management in Knee Arthroplasty: A Randomized, Double-Blind Study Anesth. Analg., August 1, 2007; 105(2): 465 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barak, O. Jurim, R. Tal, and Y. Katz Prolonged international normalized ratio correlates with a large intravascular fluid balance after major abdominal surgery. Anesth. Analg., August 1, 2006; 103(2): 448 - 52, table of contents. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. von Roten, C. Madjdpour, P. Frascarolo, M.-A. Burmeister, A. Fisch, S. Schramm, T. Bombeli, and D. R. Spahn Molar substitution and C2/C6 ratio of hydroxyethyl starch: influence on blood coagulation Br. J. Anaesth., April 1, 2006; 96(4): 455 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Gu and P. W. Boonstra Selection of priming solutions for cardiopulmonary bypass in adults MMCTS, January 9, 2006; 2006(0109): 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Van der Linden, S. G. De Hert, D. Deraedt, S. Cromheecke, K. De Decker, R. D. Paep, I. Rodrigus, A. Daper, and A. Trenchant Hydroxyethyl Starch 130/0.4 Versus Modified Fluid Gelatin for Volume Expansion in Cardiac Surgery Patients: The Effects on Perioperative Bleeding and Transfusion Needs Anesth. Analg., September 1, 2005; 101(3): 629 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arellano, B. S. Gan, M. J. Salpeter, E. Yeo, S. McCluskey, R. Pinto, J. Irish, D. C. Ross, D. J. Doyle, J. Parkin, et al. A Triple-Blinded Randomized Trial Comparing the Hemostatic Effects of Large-Dose 10% Hydroxyethyl Starch 264/0.45 Versus 5% Albumin During Major Reconstructive Surgery Anesth. Analg., June 1, 2005; 100(6): 1846 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Madjdpour, N. Dettori, P. Frascarolo, M. Burki, M. Boll, A. Fisch, T. Bombeli, and D. R. Spahn Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics? Br. J. Anaesth., May 1, 2005; 94(5): 569 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
The SAFE Study Investigators A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit N. Engl. J. Med., May 27, 2004; 350(22): 2247 - 2256. [Abstract] [Full Text] [PDF] |
||||
|